• FirefoxInstall the new Firefox »
  •  Dow Down0.58% Nasdaq Down0.26%

    Meridian Bioscience, Inc. (VIVO)

    20.06 Up 0.06(0.30%) Mar 4, 4:00PM EST
    |After Hours : 19.94 Down 0.12 (0.58%) Mar 4, 4:27PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Meridian Bioscience, Inc.
    3471 River Hills Drive
    Cincinnati, OH 45244
    United States - Map
    Phone: 513-271-3700
    Fax: 513-271-3762
    Website: http://www.meridianbioscience.com

    Index Membership:N/A
    Industry:Diagnostic Substances
    Full Time Employees:550

    Business Summary 

    Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company operates through Diagnostics and Life Science segments. It offers testing platforms and technologies, such as isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays under the Illumigene, TRU, ImmunoCard, ImmunoCard STAT!, and Premier brands; and transport media that store and preserve specimen samples from patient collection to laboratory testing. The company’s diagnostic products primarily include C. difficile for the detection of antibiotic-associated diarrhea from a hospital-acquired infection; foodborne products, such as tests for Enterohemorrhagic E. coli and Campylobacter jejuni; Helicobacter pylori for the detection of peptic ulcers; and respiratory products. Its diagnostic products are primarily used in the detection of various infectious diseases caused by bacteria, viruses, parasites, and pathogens. The company also offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies; and contract development and manufacturing services under clinical cGMP conditions for biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. Meridian Bioscience, Inc. markets its products through direct sales force and independent distributors primarily to acute care hospitals, reference laboratories, and outpatient clinics in approximately 60 countries worldwide. The company was founded in 1976 and is headquartered in Cincinnati, Ohio.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Meridian Bioscience, Inc.

    Corporate Governance 
    Meridian Bioscience, Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 8. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 6; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. John A. Kraeutler , 67
    Chairman and Chief Exec. Officer
    Ms. Melissa A. Lueke , 52
    Chief Financial Officer, Principal Financial & Accounting Officer, Exec. VP and Sec.
    Mr. Richard L. Eberly , 54
    Exec. VP and Pres of Meridian Life Science
    Dr. Vecheslav A. Elagin Ph.D., 48
    Exec. VP of R&D
    Mr. Marco J. Calzavara , 61
    Pres of Meridian Bioscience Europe and Managing Director of Meridian Bioscience Europe
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders